Results 111 to 120 of about 3,917,698 (342)
Mycosis Fungoides Is a Proliferation of Multiple Mutational Subclones
The Journal of Dermatology, EarlyView.ABSTRACT Mycosis fungoides (MF) is a unique type of lymphoma with an excellent prognosis presenting with a wide variety of clinical and histological findings. Recent sophisticated research techniques have revealed that very slow changes in the clinical and histological pictures of one patient over time are due to intratumoral heterogeneity.
Ryoma Honda +2 more
wiley +1 more source
Journal of Forensic Sciences, EarlyView.Abstract This study investigated links between skeletal age estimation error and lifestyle variables to better elucidate sources of interpersonal variability in the rates of skeletal aging. Skeletal age for 180 individuals from the New Mexico Decedent Image Database was estimated by applying the Suchey–Brooks method and transition analysis to 3D models
Natalie Moss, Elizabeth Craig‐Atkins
wiley +1 more source
Does Sickle Cell Anaemia Have a Relationship With Avascular Pulp Necrosis? A Systematic Review
Australian Endodontic Journal, EarlyView.ABSTRACT This systematic review examined the relationship between sickle cell disease (SCD), an inherited genetic hemoglobinopathy, and avascular pulp necrosis (APN) in intact teeth. A comprehensive search of eight electronic databases was performed up to December 2024.
Elidiane Elias Ribeiro +5 more
wiley +1 more source
Asia-Pacific Journal of Clinical Oncology, EarlyView.Skin adverse events (AEs) frequently accompany all types of anticancer treatments. This publication discusses how recent international guidance on best‐practices use of dermocosmetics can be adapted to the North Asia region (China, Hong Kong, Japan, Republic of Korea, and Taiwan).
Meng Pan +9 more
wiley +1 more source
Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions
Allergy, EarlyView.ABSTRACT Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases worldwide. The clinical presentation of AD is heterogeneous and is characterized by a relapsing and remitting course. Most patients suffer from mild AD while approximately 5% to 20% experience severe disease activity, which often requires systemic treatment ...
Marjolein S. de Bruin‐Weller +9 more
wiley +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
British Journal of Pharmacology, EarlyView.Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
Fixed drug eruption induced by atenolol
Clinical, Cosmetic and Investigational Dermatology, 2009 H Belhadjali, O Trimech, M Youssef, I Elhani, J ZiliDepartment of Dermatology, Fattouma Bourguiba Hospital, Monastir, Tunisia Abstract: Fixed drug eruption (FDE) is characterized by recurrent well-defined lesions in the same location each time ...
H Belhadjali +4 more
doaj
British Journal of Pharmacology, EarlyView.Background and Purpose Bruton tyrosine kinase (Btk) is essential for B cell function. Its role in myeloid cells is less understood. Greater insights into Btk significance in myeloid cells are needed to evaluate its potential as a therapeutic target during the effector phase of antibody‐induced autoimmune diseases, where inhibiting autoantibody ...
Henning Olbrich +7 more
wiley +1 more source